Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-12-025292
Filing Date
2012-05-01
Accepted
2012-05-01 16:17:34
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v309834_10q.htm 10-Q 219213
2 EXHIBIT 31.1 v309834_ex31-1.htm EX-31.1 8883
3 EXHIBIT 31.2 v309834_ex31-2.htm EX-31.2 8767
4 EXHIBIT 32.1 v309834_ex32-1.htm EX-32.1 4256
  Complete submission text file 0001144204-12-025292.txt   1386852

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20120331.xml EX-101.INS 140700
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20120331.xsd EX-101.SCH 15166
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20120331_cal.xml EX-101.CAL 24640
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20120331_def.xml EX-101.DEF 80021
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20120331_lab.xml EX-101.LAB 107304
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20120331_pre.xml EX-101.PRE 95736
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

EIN.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 12800878
SIC: 2834 Pharmaceutical Preparations